NTCP and Secondary Cancer Risk in Modulated Arc Therapy for Prostate Carcinoma

Prostate cancer, a significant health concern worldwide, has seen advancements in treatment with the adoption of IMRT. However, the use of radiotherapy poses risks of inducing secondary cancers due to organ toxicity. A study presented at ICARO3 focused on evaluating the toxicity of organs at risk an

0 views • 6 slides